Skip to main content
Equibles

ORBIMED ADVISORS LLC

Position in CMPX — Compass Therapeutics, Inc.

CIK 1055951 New York, NY
Back to CMPX Full portfolio

Position in CMPX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$33,331,786
-$47,181,982 QoQ
Shares Held
15,219,994
0.0% QoQ
Ownership
8.45%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CMPX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. CMPX ranks #31 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EWTX
Edgewise Therapeutics, Inc.
 15,518,492 $630,516,329
2 ELVN
Enliven Therapeutics, Inc.
 6,776,632 $343,914,074
3 MBX
MBX Biosciences, Inc.
 3,428,736 $189,266,227
4 GPCR
Structure Therapeutics Inc.
 2,209,400 $118,578,498
5 SION
Sionna Therapeutics, Inc.
 2,555,877 $112,433,029
6 CRVS
Corvus Pharmaceuticals, Inc.
 7,165,006 $107,045,189
7 AVBP
ArriVent BioPharma, Inc.
 3,027,328 $105,169,374
8 ARGX
Argenx SE
 92,880 $86,171,277

All Filings in CMPX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,331,786 15,219,994
2026-03-31 $80,513,768 15,219,994
2025-12-31 $81,731,367 15,219,994
2025-09-30 $53,269,979 15,219,994
2025-06-30 $39,571,984 15,219,994
2025-03-31 $42,489,415 22,362,850
2024-12-31 $32,426,132 22,362,850
2024-09-30 $41,147,644 22,362,850
2024-06-30 $22,362,850 22,362,850
2024-03-31 $44,278,443 22,362,850
2023-12-31 $34,886,046 22,362,850
2023-09-30 $44,054,814 22,362,850
2023-06-30 $71,113,863 22,362,850
2023-03-31 $73,126,519 22,362,850
2022-12-31 $112,485,135 22,362,850
2022-09-30 $50,070,738 21,960,850
2022-06-30 $58,196,252 21,960,850
2022-03-31 $29,650,875 21,642,975
2021-12-31 $68,608,230 21,642,975